Serum biomarkers of brain injury: S100B protein, cognitive dysfunction, and major non-cardiac surgery

[1]  Ali Sait Kavakli,et al.  Nível de S100B e disfunção cognitiva após prostatectomia radical laparoscópica assistida por robô: estudo observacional prospectivo , 2020 .

[2]  F. Guzen,et al.  S100B protein: general characteristics and pathophysiological implications in the Central Nervous System , 2020, The International journal of neuroscience.

[3]  Shamsher Singh,et al.  Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders , 2020, Current neuropharmacology.

[4]  D. Souza,et al.  S100B protein and neuron-specific enolase as predictors of postoperative cognitive dysfunction in aged dogs: a case-control study. , 2020, Veterinary anaesthesia and analgesia.

[5]  K. Blennow,et al.  Neuroinflammatory markers associate with cognitive decline after major surgery: Findings of an explorative study , 2020, Annals of neurology.

[6]  C. Olotu Postoperative neurocognitive disorders. , 2019, Current opinion in anaesthesiology.

[7]  F. Michetti,et al.  The S100B story: from biomarker to active factor in neural injury , 2018, Journal of neurochemistry.

[8]  B. Silbert,et al.  Postoperative Cognitive Dysfunction and Noncardiac Surgery , 2018, Anesthesia and analgesia.

[9]  O. Tucha,et al.  Neuronal damage biomarkers in the identification of patients at risk of long‐term postoperative cognitive dysfunction after cardiac surgery , 2017, Anaesthesia.

[10]  A. Tort,et al.  S100B protein and neuron-specific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery: A prospective observational study , 2016, European journal of anaesthesiology.

[11]  R. Pietrobon,et al.  Effects of Single Low Dose of Dexamethasone before Noncardiac and Nonneurologic Surgery and General Anesthesia on Postoperative Cognitive Dysfunction—A Phase III Double Blind, Randomized Clinical Trial , 2016, PloS one.

[12]  A. Absalom,et al.  Postoperative cognitive dysfunction: Involvement of neuroinflammation and neuronal functioning , 2014, Brain, Behavior, and Immunity.

[13]  W. Ouyang,et al.  Role of Peripheral Inflammatory Markers in Postoperative Cognitive Dysfunction (POCD): A Meta-Analysis , 2013, PloS one.

[14]  E. F. Bruggemans,et al.  Cognitive dysfunction after cardiac surgery: Pathophysiological mechanisms and preventive strategies , 2013, Netherlands Heart Journal.

[15]  R. Abaza,et al.  Anesthetic considerations for robotic prostatectomy: a review of the literature. , 2012, Journal of clinical anesthesia.

[16]  D. Souza,et al.  Neuron-Specific Enolase, S100B, and Glial Fibrillary Acidic Protein Levels as Outcome Predictors in Patients With Severe Traumatic Brain Injury , 2011, Neurosurgery.

[17]  L. Rasmussen,et al.  Long-term Consequences of Postoperative Cognitive Dysfunction , 2009, Anesthesiology.

[18]  O. Amaral,et al.  Serum S100B in pregnancy-related hypertensive disorders: a case-control study. , 2004, Clinical chemistry.

[19]  Mark F. Newman,et al.  Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. , 2001, The New England journal of medicine.

[20]  M. Christiansen,et al.  Do blood levels of neuron‐specific enolase and S‐100 protein reflect cognitive dysfunction after coronary artery bypass? , 1999, Acta anaesthesiologica Scandinavica.